miR-199a-3p plays an anti-tumorigenic role in lung adenocarcinoma by suppressing anterior gradient 2

References

• Fitzmaurice C, Abate D, Abbasi N, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5:1749–1768.
   PubMed Web of Science ®Google Scholar
• Kim N, Kim HK, Lee K, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285.
   PubMed Web of Science ®Google Scholar
• Sun Y, Luo J, Chen Y, et al. Combined evaluation of the expression status of CD155 and TIGIT plays an important role in the prognosis of LUAD (lung adenocarcinoma). Int Immunopharmacol. 2020;80:106198.
   PubMed Web of Science ®Google Scholar
• How CW, Ong YS, Low SS, et al. How far have we explored fungi to fight cancer? Semin Cancer Biol. 2021. DOI:10.1016/j.semcancer.2021.03.009
   PubMed Web of Science ®Google Scholar
• Chang YS, Choi CM, Lee JC. Mechanisms of epidermal growth factor receptor tyrosine kinase inhibitor resistance and strategies to overcome resistance in lung adenocarcinoma. Tuberc Respir Dis (Seoul). 2016;79(4):248–256.
   PubMedGoogle Scholar
• Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127–D131.
   PubMed Web of Science ®Google Scholar
• Qiao Y, Zhao X, Liu J, et al. Epstein-Barr virus circRNAome as host miRNA sponge regulates virus infection, cell cycle, and oncogenesis. Bioengineered. 2019;10(1):593–603.
   PubMed Web of Science ®Google Scholar
• Li XT, Wang HZ, Wu ZW, et al. miR-494-3p regulates cellular proliferation, invasion, migration, and apoptosis by PTEN/AKT signaling in human glioblastoma cells. Cell Mol Neurobiol. 2015;35(5):679–687.
   PubMed Web of Science ®Google Scholar
• Chae DK, Park J, Cho M, et al. MiR-195 and miR-497 suppress tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF-β receptor I ubiquitination. Mol Oncol. 2019;13(12):2663–2678.
   PubMed Web of Science ®Google Scholar
• Lin HY, Chu PY. Advances in understanding mitochondrial micrornas (mitomirs) on the pathogenesis of Triple-Negative Breast Cancer (TNBC). Oxid Med Cell Longev. 2021;5517777.
   PubMed Web of Science ®Google Scholar
• Wang S, Qiu J, Wang L, et al. Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1. IUBMB Life. 2020;72(9):1960–1975.
   PubMed Web of Science ®Google Scholar
• Wang W, Hong G, Wang S, et al. Tumor-derived exosomal miRNA-141 promote angiogenesis and malignant progression of lung cancer by targeting growth arrest-specific homeobox gene (GAX). Bioengineered. 2021;12(1):821–831.
   PubMed Web of Science ®Google Scholar
• Yajie C, Fengqin W, Defu T, Ting W, Tianjie L, Xiying H, Peilian Z, Li Q. miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8. Oncol Rep. 2018;39:1649–1657.
   PubMed Web of Science ®Google Scholar
• Phatak P, Burrows WM, Chesnick IE, et al. MiR-199a-3p decreases esophageal cancer cell proliferation by targeting p21 activated kinase 4. Oncotarget. 2018;9(47):28391–28407.
   PubMedGoogle Scholar
• Li L, Mou YP, Wang YY, et al. miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis. Pathol Res Pract. 2019;215(9):152511.
   PubMed Web of Science ®Google Scholar
• Qu F, Zheng J, Gan W, et al. MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1. Oncotarget. 2017;8(32):52465–52473.
   PubMedGoogle Scholar
• Huang J, Dong B, Zhang J, et al. miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma. Tumour Biol. 2014;35(6):5833–5843.
   PubMedGoogle Scholar
• Ghosh A, Dasgupta D, Ghosh A, et al. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2. Cell Death Dis. 2017;8(3):e2706.
   PubMed Web of Science ®Google Scholar
• Ecke TH, Stier K, Weickmann S, et al. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy. Cancer Med. 2017;6(10):2252–2262.
   PubMed Web of Science ®Google Scholar
• Bai J, Jiao WY. Down-Regulation of ZEB1 by miR-199a-3p overexpression restrains tumor stem-like properties and mitochondrial function of non-small cell lung cancer. Onco Targets Ther. 2020;13:4607–4616.
   PubMed Web of Science ®Google Scholar
• Luu TT, Bach DH, Kim D, et al. Overexpression of AGR2 is associated with drug resistance in mutant non-small cell lung cancers. Anticancer Res. 2020;40(4):1855–1866.
   PubMed Web of Science ®Google Scholar
• Dahal Lamichane B, Jung SY, Yun J, et al. AGR2 is a target of canonical Wnt/β-catenin signaling and is important for stemness maintenance in colorectal cancer stem cells. Biochem Biophys Res Commun. 2019;515(4):600–606.
   PubMed Web of Science ®Google Scholar
• Liu C, Wang JO, Zhou WY, et al. Long non-coding RNA LINC01207 silencing suppresses AGR2 expression to facilitate autophagy and apoptosis of pancreatic cancer cells by sponging miR-143-5p. Mol Cell Endocrinol. 2019;493:110424.
   PubMed Web of Science ®Google Scholar
• Zhang J, Jin Y, Xu S, et al. AGR2 is associated with gastric cancer progression and poor survival. Oncol Lett. 2016;11(3):2075–2083.
   PubMed Web of Science ®Google Scholar
• Liu QG, Li YJ, Yao L. Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis, pancreatology: official. journal of the International Association of Pancreatology. 2018;18(6):678–688.
   PubMed Web of Science ®Google Scholar
• Alavi M, Mah V, Maresh EL, et al. High expression of AGR2 in lung cancer is predictive of poor survival. BMC Cancer. 2015;15(1):655.
   PubMed Web of Science ®Google Scholar
• Xue X, Fei X, Hou W, et al. miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer. Cancer Lett. 2018;412:170–178.
   PubMed Web of Science ®Google Scholar
• Tiemann K, Garri C, Lee SB, et al. Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. Oncogene. 2019;38(16):3003–3018.
   PubMed Web of Science ®Google Scholar
• Callegari E, D’Abundo L, Guerriero P, et al. miR-199a-3p modulates MTOR and PAK4 pathways and inhibits tumor growth in a hepatocellular carcinoma transgenic mouse model, molecular therapy. Molecular Therapy - Nucleic Acids. 2018;11:485–493.
   Google Scholar
• Rao X, Huang X, Zhou Z, et al. An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath. 2013;3:71–85.
   PubMedGoogle Scholar
• Leidinger P, Galata V, Backes C, et al. Longitudinal study on circulating miRNAs in patients after lung cancer resection. Oncotarget. 2015;6(18):16674–16685.
   PubMedGoogle Scholar
• Xu L, Lu C, Huang Y, et al. SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker. BMB Rep. 2018;51(12):648–653.
   PubMed Web of Science ®Google Scholar
• Zang C, Zhao F, Hua L, et al. The miR-199a-3p regulates the radioresistance of esophageal cancer cells via targeting the AK4 gene. Cancer Cell Int. 2018;18(1):186.
   PubMed Web of Science ®Google Scholar
• Wang Z, Ma X, Cai Q, et al. MiR-199a-3p promotes gastric cancer progression by targeting ZHX1. FEBS Lett. 2014;588(23):4504–4512.
   PubMed Web of Science ®Google Scholar
• Lu H, Hu J, Li J, et al. miR-328-3p overexpression attenuates the malignant proliferation and invasion of liver cancer via targeting endoplasmic reticulum metallo protease 1 to inhibit AKT phosphorylation. Ann Transl Med. 2020;8(12):754.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li T, Chen G, et al. Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p. Lung Cancer. 2017;114:6–11. [ (Amsterdam, Netherlands)].
   PubMed Web of Science ®Google Scholar
• He Y, Ren S, Wang Y, et al. Serum microRNAs improving the diagnostic accuracy in lung cancer presenting with pulmonary nodules. J Thorac Dis. 2018;10(8):5080–5085.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xia F, Zhang F, et al. miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2. J Exp Clin Cancer Res. 2019;38(1):26.
   PubMed Web of Science ®Google Scholar
• Sung HY, Choi EN, Lyu D, et al. Aberrant hypomethylation-mediated AGR2 overexpression induces an aggressive phenotype in ovarian cancer cells. Oncol Rep. 2014;32(2):815–820.
   PubMed Web of Science ®Google Scholar
• Tu MJ, Pan YZ, Qiu JX, et al. MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis. Oncotarget. 2016;7(29):45547–45561.
   PubMedGoogle Scholar
• Chung K, Nishiyama N, Wanibuchi H, et al. AGR2 as a potential biomarker of human lung adenocarcinoma. Osaka city medical journal. 2012;58:13–24.
   PubMedGoogle Scholar
• Chung K, Nishiyama N, Yamano S, et al. Serum AGR2 as an early diagnostic and postoperative prognostic biomarker of human lung adenocarcinoma. Cancer Biomarkers. 2011;10(2):101–107.
   PubMed Web of Science ®Google Scholar
• Pizzi M, Fassan M, Balistreri M, et al. Anterior gradient 2 overexpression in lung adenocarcinoma. AIMM. 2012;20(1):31–36.
   Google Scholar